General Classification of Contraceptive Agents
In modern pharmacology, pregnancy prevention agents are divided into several main groups. The basic classification of hormonal contraceptives includes the following categories:
- Combined estrogen-progestin contraceptives (COCs) — the main and most extensive group on which most family planning regimens are based.
- Progestin-only pills (POPs) — also known in medical practice as mini-pills.
- Emergency contraceptives — a specific group of postcoital drugs used after unprotected intercourse.
Composition and Safety of Combined Preparations
Classical combined oral contraceptives consist of two active substances. The estrogenic component in the vast majority of cases is represented by ethinyl estradiol. Various synthetic progesterone analogs act as the progestin component.
It is important to understand the interaction of these components. The dominant contraceptive effect is always provided specifically by the progestin component. The role of estrogens is that they potentiate (significantly enhance) the inhibitory effect of progestins on the secretion of pituitary gonadotropins.
However, the presence of estrogens requires strict safety monitoring. Systematic intake of estrogens stimulates the synthesis of procoagulants (blood clotting factors) in the liver, which directly increases the risk of thrombosis. To minimize the probability of thromboembolic complications, pharmacologists limit the dosage: in modern pills, the estrogen content typically does not exceed 35 mcg.
Depending on the variation of hormone doses throughout the menstrual cycle, COCs are divided into 3 types: monophasic (with a constant dose of both components), biphasic, and triphasic.
Mechanism of Contraceptive Action
The action of combined preparations is implemented simultaneously at two levels: central and peripheral.
1. Central Action (Suppression of Ovulation) Mediated through effects on the pituitary gland:
- Estrogen effect: acting via negative feedback, they suppress follicle-stimulating hormone (FSH) production during the proliferative phase of the cycle. As a result, the growth and maturation of ovarian follicles are slowed.
- Progestin effect: they purposefully inhibit the release of pituitary luteinizing hormone (LH). The net result of this combined action is the complete blockade of ovulation.
2. Peripheral Action (Progestic Effects) Even if ovulation occurs, additional protection is triggered at the target organ level:
- Cervical factor: under the influence of the drugs, the cervical glands produce very thick and viscous mucus. This creates a reliable mechanical barrier preventing sperm penetration into the uterine cavity.
- Tubal factor: there is a pronounced decrease in fallopian tube peristalsis. This causes impaired egg transport — it reaches the uterus untimely, making fertilization impossible.
- Uterine factor: the drugs cause profound structural changes in the endometrium. As a result, implantation of an already fertilized egg is made impossible. This mechanism is classified as abortifacient and is also used in medicine for pregnancy termination.